- Home
- IQ vs SLNO Comparison
IQ vs SLNO Comparison
Compare IQ & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQ
- SLNO
- Stock Information
- Founded
- IQ 2009
- SLNO 1999
- Country
- IQ China
- SLNO United States
- Employees
- IQ N/A
- SLNO N/A
- Industry
- IQ Consumer Electronics/Video Chains
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IQ Consumer Discretionary
- SLNO Health Care
- Exchange
- IQ Nasdaq
- SLNO Nasdaq
- Market Cap
- IQ 2.2B
- SLNO 2.3B
- IPO Year
- IQ 2018
- SLNO 2014
- Fundamental
- Price
- IQ $2.23
- SLNO $68.26
- Analyst Decision
- IQ Hold
- SLNO Strong Buy
- Analyst Count
- IQ 5
- SLNO 8
- Target Price
- IQ $2.60
- SLNO $95.75
- AVG Volume (30 Days)
- IQ 36.7M
- SLNO 2.0M
- Earning Date
- IQ 05-15-2025
- SLNO 05-08-2025
- Dividend Yield
- IQ N/A
- SLNO N/A
- EPS Growth
- IQ N/A
- SLNO N/A
- EPS
- IQ 0.11
- SLNO N/A
- Revenue
- IQ $4,003,950,893.00
- SLNO N/A
- Revenue This Year
- IQ $2.98
- SLNO N/A
- Revenue Next Year
- IQ $3.40
- SLNO N/A
- P/E Ratio
- IQ $21.42
- SLNO N/A
- Revenue Growth
- IQ N/A
- SLNO N/A
- 52 Week Low
- IQ $1.82
- SLNO $36.61
- 52 Week High
- IQ $5.80
- SLNO $73.97
- Technical
- Relative Strength Index (RSI)
- IQ 47.38
- SLNO 74.69
- Support Level
- IQ $2.18
- SLNO $48.29
- Resistance Level
- IQ $2.47
- SLNO $73.97
- Average True Range (ATR)
- IQ 0.13
- SLNO 3.37
- MACD
- IQ -0.01
- SLNO 2.59
- Stochastic Oscillator
- IQ 16.22
- SLNO 79.51
About IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.